Mutations of SLC6A1 were reported in a variety of neurological and psychiatric disorders, myoclonic atonic epilepsy, intellectual disability (Johannesen et al., 2018, 1), autism (Wang et al., 2020), as well as schizophrenia (Rees et al., 2020). This evidence concerns the gene SLC6A1 and autism.